CSL gets European OK for Novartis flu vaccines purchase; GSK's malaria vax may pick up key approval Friday;

> CSL received regulatory approval from the European Commission on its deal to buy Novartis' ($NVS) flu vaccine business, though the deal has not closed yet. Report

> European regulators could recommend GlaxoSmithKline's ($GSK) malaria vaccine--the world's first such shot--on Friday, Reuters reported. Story

> Focusing on blocking the disease's transmission process, a professor from Oklahoma University is working to develop a malaria vaccine. Report

And Finally... Portland State University virologists discovered how to neutralize viruses by coating them in silica and then bring them back to life by removing the coat--the team dubbed them "zombie viruses." Report

Suggested Articles

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.

Since the FDA released new COVID-19 vaccine guidance, HHS Secretary Alex Azar has discussed firing FDA Commissioner Stephen Hahn, Politico reports.